ATRA reduces inflammation and improves alveolar epithelium regeneration in emphysematous rat lung.

Biomed Pharmacother

Department of Biotechnology, School of Biotechnology, Gautam Buddha University, Greater Noida, 201308, Uttar Pradesh, India. Electronic address:

Published: December 2018

Introduction: Pulmonary emphysema characterized by alveolar wall destruction is resultant of persistent chronic inflammation. All-trans retinoic acid (ATRA) has been reported to reverse elastase-induced emphysema in rats. However, the underlying molecular mechanisms are so far unknown.

Objective: To investigate the therapeutic potential effect of ATRA via the amelioration of the ERK/JAK-STAT pathways in the lungs of emphysematous rats.

Methods: In silico analysis was done to find the binding efficiency of ATRA with receptor and ligands of ERK & JAK-STAT pathway. Emphysema was induced by porcine pancreatic elastase in Sprague-Dawley rats and ATRA was supplemented as therapy. Lungs were harvested for histopathological, genomics and proteomics analysis.

Results And Discussion: In silico docking, analysis confirms that ATRA interferes with the normal binding of ligands (TNF-α, IL6ST) and receptors (TNFR1, IL6) of ERK/JAK-STAT pathways respectively. ATRA restored the histology, proteases/antiproteases balance, levels of inflammatory markers, antioxidants, expression of candidate genes of ERK and JAK-STAT pathways in the therapy group.

Conclusion: ATRA ameliorates ERK/JAK-STAT pathway in emphysema condition, resulting in alveolar epithelium regeneration. Hence, ATRA may prove to be a potential drug in the treatment of emphysema.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2018.09.166DOI Listing

Publication Analysis

Top Keywords

atra
9
alveolar epithelium
8
epithelium regeneration
8
erk/jak-stat pathways
8
erk jak-stat
8
pathway emphysema
8
emphysema
5
atra reduces
4
reduces inflammation
4
inflammation improves
4

Similar Publications

Following a recent dramatic increase in illegal fishing by Indonesian fishing vessels in Australian waters in 2022, we conducted an extensive survey of coral reef communities covering 33,000 m at Mermaid Reef Marine Park in the Rowley Shoals off north-western Australia in July 2022. Species richness of sea cucumbers was 13 species (three CITES listed) and 6 species of giant clams (all CITES listed). The most abundant sea cucumber species were the low or intermediate value, asexually reproducing species Holothuria atra and H.

View Article and Find Full Text PDF

Differentiation of Human Mesenchymal Stem Cells into Corneal Epithelial Cells: Current Progress.

Curr Issues Mol Biol

November 2024

Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.

The limited availability of corneal tissue grafts poses significant challenges in the treatment of corneal blindness. Novel treatment utilizes stem cell grafts transplanted from the healthy side of the cornea to the damaged side. However, this procedure is only possible for those who have one-sided corneal blindness.

View Article and Find Full Text PDF

Aims: Acute promyelocytic leukemia (APL) progresses quickly and often leads to early hemorrhagic death. Treatment with all-trans retinoic acid (ATRA) promotes differentiation of APL cells and clinical remission, making APL a potentially curable malignancy. Understanding how ATRA works may lead to new treatments for other types of leukemia.

View Article and Find Full Text PDF

Purpose: Ambient light exposure is linked to myopia development in children and affects myopia susceptibility in animal models. Currently, it is unclear which signals mediate the effects of light on myopia. All- retinoic acid (atRA) and dopamine (DA) oppositely influence experimental myopia and may be involved in the retino-scleral signaling cascade underlying myopic eye growth.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!